13F Filings History of Sanofi

Latest 13F filing: Q2 2026 - 28 Jul 2026
Latest reported 13F value: $534,041,662
Largest 13F holdings: MGTX INBX NVAX ANAB ODTX AGMB MPLT TRAX IMRX QTTB
Form 13F summary: Sanofi Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
Form 13F is generally due within 45 days after each calendar quarter ends.
Sanofi reported 10 equity holdings with a total reported market value of $534,041,662 for Q2 2026. Top reported holdings included MGTX, INBX, NVAX, ANAB, and ODTX.
Manager signature: Alexandra Roger - Head of Legal Corporate & Finance
Manager location: Paris, France

Follow Filing Activity

Follow Sanofi with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter

Q2 2026

Latest value

$534,041,662

Quarter delta

+$198,082,507

Accepted

28 Jul 2026, 06:15

Rows shown

1-7 of 7

Quarter	Holdings	SEC-reported value	Bought	Sold	Net	Top Holdings	Form Type	Accepted by SEC
Q2 2026	10	$534,041,662	+$53,805,756	-$2,510,138	+$51,295,618	MGTX, INBX, NVAX, ANAB, ODTX	13F-HR	28 Jul 2026, 06:15
Q1 2026	9	$335,959,155	+$29,194,677	$0	+$29,194,677	MGTX, INBX, NVAX, ANAB, AGMB	13F-HR	07 May 2026, 08:47
Q4 2025	8	$310,414,825	+$16,020,000	-$14,599,955	+$1,420,045	MGTX, INBX, NVAX, ANAB, IMRX	13F-HR	11 Feb 2026, 08:47
Q3 2025	9	$260,361,143	+$18,959,913	-$3,384,672	+$15,575,241	MGTX, NVAX, INBX, ANAB, IMRX	13F-HR	04 Nov 2025, 10:51
Q2 2025	10	$175,742,794	+$9,605,725	$0	+$9,605,725	MGTX, NVAX, ANAB, INBX, OMDA	13F-HR	29 Jul 2025, 12:18
Q1 2025	9	$165,944,772	$0	$0	$0	MGTX, NVAX, INBX, ANAB, ELDN	13F-HR	06 May 2025, 06:15
Q4 2024	9	$174,360,245	$0	$0	$0	MGTX, NVAX, INBX, ANAB, IGMS	13F-HR	14 Feb 2025, 11:28